로딩 중…
지수 로딩 중…
ADC Therapeutics S.A.
ADCT· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
CH
CH$1.05+0.48%
2026-08-03
Financials
Valuation Metrics
ADC Therapeutics S.A.'s Market Cap is $134M. At end of 2025 it was $531M. Ranked #3063 of 3,112 in US market (top 98%), #1659 of 1,667 on NYSE (top 100%), #264 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 98%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $134M | US#3,063/3,112 Sec#264/269 |
| Revenue | $79M | US#2,823/3,112 Sec#137/269 |
| Net Income | $-137M | US—/3,112 Sec—/269 |
| Total Assets | $291M | US#2,905/3,112 Sec#215/269 |
| Net Assets | $38M | US#2,953/3,112 Sec#246/269 |
| Value | ||
| P/B | 3.56x | US#1,857/3,112 Sec#110/269 |
| P/S | 1.69x | US#1,082/3,112 Sec#22/269 |
| FCF Yield | -85.40% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROA | -47.00% | US#2,956/3,112 Sec#209/269 |
| Op. Margin | -148.84% | US#2,841/3,112 Sec#130/269 |
| Revenue Growth | -9.47% | US#2,650/3,112 Sec#145/269 |
| Financial Health | ||
| Debt Ratio | 1347.68% | US#2,846/3,112 Sec#253/269 |
| Total Debt | $117M | US#2,339/3,112 Sec#109/269 |
| FCF | $-115M | US#2,611/3,112 Sec#160/269 |
| Cash | $231M | US#1,619/3,112 Sec#101/269 |
| Current Ratio | 4.09x | US#586/3,112 Sec#167/269 |
| Performance | ||
| 1Y Return | -60.78% | US#3,048/3,112 Sec#258/269 |
| 1M Return | -11.34% | US#2,670/3,112 Sec#179/269 |
| From 52W High | -78.82% | US#3,081/3,112 Sec#265/269 |
| 1Y MDD | -79.97% | US#3,046/3,112 Sec#261/269 |
| Trading | ||
| Volume | 665,094 shares | US#1,847/3,112 Sec#180/269 |
| Trading Value | $698348.00 | US#3,055/3,112 Sec#262/269 |
| Per Share | ||
| EPS | $-0.95 | US—/3,112 Sec—/269 |